The TREAT PTSD VA Act directs the Department of Veterans Affairs to provide stellate ganglion block treatment to enrolled veterans who have been diagnosed with post-traumatic stress disorder and choose to receive it. Stellate ganglion block is a nerve block procedure that emerging research suggests may help relieve PTSD symptoms. The VA can deliver this treatment either through its own medical facilities or through outside health care providers. Within 180 days of the bill's enactment, the VA must update its clinical practice guideline for PTSD management to include information about stellate ganglion block as a treatment option, including when it is appropriate to use and when it should be avoided. The bill becomes effective 180 days after passage and affects all veterans enrolled in the VA health system who have PTSD.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.